Invasive Haemophilus influenzae type b disease in elderly nursing home residents: two related cases. by Heath, T. C. et al.
179 Vol. 3, No. 2, April–June 1997 Emerging Infectious Diseases
Dispatches
After the introduction of routine childhood
immunization against Haemophilus influenzae
type b (Hib), the incidence of invasive Hib disease
fell dramatically in several countries, including
Australia (1-3). This decline has been most evi-
dent among children aged less than 5 years. Mean-
while, serious Hib infections, such as pneumonia
and epiglottitis, have been increasingly recognized
among elderly, debilitated, and immunosuppressed
adults (4-6). However, clusters of Hib infection
have rarely been reported in adults. To examine
their relatedness, we investigated two fatal cases
of Hib septicemia in a community nursing home.
Case Reports
Case 1
In June 1996, a 71-year-old female nursing
home resident was hospitalized after 3 days of
unproductive cough, fevers, confusion, and
increasing dyspnea. She had a history of cere-
brovascular disease, muscular dystrophy, and
congestive heart failure and was confined to a
wheelchair. She had clinical signs of left lower
lobe pneumonia and was afebrile. A blood film
was normal, but a chest X-ray showed exten-
sive bilateral pulmonary infiltrates. Arterial
blood gases showed severe hypoxia in room air
(PO2 44 mm Hg, saturation 77%). Ceftriaxone 1 g
and metronidazole 500 mg were given intra-
venously for suspected aspiration pneumonia,
but the patient became severely hypotensive
and died 8 hours after admission to the
hospital. The following day, beta-lactamase-
negative Hib was isolated from blood cultures
collected before the patient died.
Case 2
Two days after the first patient was
hospitalized, an 80-year-old female resident of
the same nursing home became ill with fever and
sore throat. She had a history of chronic airflow
limitation, mild renal impairment, and dementia.
Her sore throat rapidly worsened, and the next
day she was hospitalized with severe dysphagia.
On examination, she was febrile (38.5°C) and
hypotensive (90/60 mm Hg) and had pretracheal
cellulitis. No clinical evidence of pneumonia was
observed, and a chest X-ray was normal. She was
intubated, and extensive epiglottitis, laryngitis,
and tracheitis were noted. Ceftriaxone 2 g, genta-
micin 80 mg, flucloxacillin 1 g, and metronidazole
500 mg were administered intravenously. Inotropes
were given for hypotension and acute renal
failure, but the patient’s condition deteriorated
rapidly, and she died 9 hours after admission to
the hospital. Beta-lactamase-negative Hib was
subsequently isolated from blood cultures col-
lected before the patient died.
Investigation
For several months, these two women had
occupied beds in the same six-bed room (the
largest room) in the 44-bed nursing home. The
home employed 37 nursing and ancillary staff.
During 3 weeks before the investigation, 20
residents and several staff had been ill with
bronchitis, for which many had received oral
antibiotics. No sputum samples had been col-
lected for culture from residents or staff. Two
other elderly residents had died during the
preceding 10 days, but their case notes did not
document any fever or symptoms suggesting
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infection. On the first day of our investigation,
two elderly residents were febrile. One woman
had bilateral bronchopneumonia that was not
responding to oral cefaclor and was hospitalized;
blood and sputum cultures yielded no pathogens,
and urine samples did not contain Hib capsular
antigen. The other woman had been febrile for 1
week, with a cellulitic leg ulcer and pleuritic
chest pain of uncertain etiology. Because of her
other chronic illnesses she was treated palliatively
and died 1 week later. A swab of her leg ulcer
yielded group G streptococcus, blood cultures
were negative, and sputum was not obtained.
Throat swabs were collected from all 81
residents and staff at the nursing home and cul-
tured for Hib on bacitracin chocolate blood agar.
We administered rifampicin chemoprophylaxis
to all roommates of the index case patients and 28
staff who had been in regular close contact with
the two case patients during the week before their
illness. No new febrile illnesses occurred during 3
weeks of follow-up, and Hib was not isolated from
any throat swab cultures. The Hib isolates from
the first and second patients were examined by
pulsed field gel electrophoresis and had identical
profiles that were distinguishable from several
epidemiologically unrelated isolates (Figure).
The relationship of these two fatal cases of
Hib disease in time and place and the clonality of
the isolates provide good evidence that trans-
mission of Hib infection occurred in this nursing
home. We were unable to demonstrate that Hib
caused any of the associated reports of bronchitis
and febrile illness among residents and staff, and
our prevalence study did not show any asymp-
tomatic Hib carriage. However, the survey was
performed 10 days after the onset of the second
case of septicemia following widespread use of
antibiotics, and it may not have accurately reflected
the prevalence of Hib carriage at the time these
cases occurred. It is also difficult to evaluate
whether chemoprophylaxis was a useful inter-
vention in this setting.
To our knowledge, this is the first reported
cluster of invasive Hib infection among adults in
a community-based nursing home. Three other
clusters of Hib infection in adults have been des-
cribed: one occurred in a nursing home attached
to a hospital, and two were nosocomialincluding
a cluster of bronchitic illness (7-9). Our report
provides further evidence that Hib can cause
clusters of serious disease among the elderlyat
least in institutions. Given that diagnostic pro-
cedures are performed infrequently in many
community nursing homes, Hib infection  may be
underrecognized in this setting.
We were especially interested in these two
cases in adults as they were the only instances of
Figure. Pulsed field gel
electrophoresis of
Haemophilus influenzae
type b (Hib) isolates from
blood culture of two elderly
nursing home residents
(lanes 1 and 2) compared
with epidemiologically
unrelated H. influenzae
isolates sent to our
laboratory for typing: lane 3,
laboratory Hib strain; lane
4, non-H. influenzae; lane 5
and 12, invasive
nontypeable H. influenzae;
lane 6-11, unrelated Hib
isolates; lane 13, H.
influenzae type a; lane 14, 1
kilobase molecular marker.
The enzyme used for DNA
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invasive Hib disease reported to this Public
Health Unit from its population base of one mil-
lion persons over 12 months—a rate of 0.3 per
100,000 population aged 15 years and older. This
pattern of notification differs markedly from that
observed in western Sydney at the time childhood
Hib vaccination was first introduced in mid-1992.
In 1992, 27 of 30 notifications of invasive Hib
disease in this area were of children aged less than
5 years, or 36.9 per 100,000 population (New
South Wales Health Department, unpub. data).
Although invasive Hib infection remains uncommon
in adults in communities where childhood Hib vac-
cination is routine, the relative frequency of inva-
sive Hib infection is increasing in older age groups.
Population-based studies of acute epiglottitis
undertaken in northern California and Rhode
Island have also shown that the incidence of
childhood epiglottitis is falling rapidly since the
introduction of Hib immunization, while the inci-
dence of epiglottitis in adults remains steady or is
increasing (10,11). Acute epiglottitis in children
is usually caused by Hib, and the falling inci-
dence of epiglottitis in this age group is explainable
by immunization. In adults, most culture-positive
cases of acute epiglottitis are also caused by Hib
(10,12). However, the incidence of Hib-related epi-
glottitis in adults does not appear to be changing
appreciably—at least in Rhode Island—and Hib
does not account for the increasing incidence of
epiglottitis observed in this age group (10).
Indeed, acute epiglottitis is frequently culture
negative in adults, so explaining its increasing
incidence and ascertaining the etiologic agents in
older age groups require further study (10,12).
Invasive Hib disease should continue to be
monitored in all age groups after the introduction
of childhood immunization against Hib. Evidence
suggests that Hib immunization reduces the
acquisition of Hib carriage in children, and
reduced carriage among children may indirectly
prevent Hib disease in adults (13). However, sur-
veillance data in western Sydney and metropolitan
Atlanta have not supported this hypothesis;
rates of adult Hib disease are remaining approxi-
mately unchanged, despite dramatic reductions
in childhood disease (5; New South Wales Health
Department, unpub. data). Only by serotyping
isolates of H. influenzae that cause invasive
disease will it be possible to detect changing
patterns of invasive Hib disease in adults during
this era of childhood immunization. Serotype-
specific surveillance of invasive H. influenzae
disease is also needed to assess progress towards
the elimination of childhood Hib disease. In addi-
tion, periodic cross-sectional serotyping studies
of H. influenzae isolates causing noninvasive
disease would help measure the effects of Hib
immunization on the incidence of less serious forms
of Hib infection. These surveillance methods will
identify groups at increasing or underrecognized
risk that may benefit from immunization.
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